NOV-002 in Myelodysplastic Syndrome (MDS)

Stopped Study withdrawn at sponsor request.

Conditions

• Leukemia
• Myelodysplastic Syndrome

Interventions

• DRUG: NOV-002

Sponsor

M.D. Anderson Cancer Center

Collaborators

• [object Object]